Related Experiment Videos
Fiberoptic bronchoscopy for refractory cough
Chest
|January 1, 1991
Summary
Fiberoptic bronchoscopy (FB) can diagnose refractory chronic cough in carefully selected patients. This study found a 28% diagnostic yield in patients with negative chest X-rays, identifying conditions like broncholithiasis and tuberculous bronchostenosis.
Area of Science:
- Pulmonology
- Diagnostic Imaging
- Respiratory Medicine
Background:
- Fiberoptic bronchoscopy (FB) has historically shown a low diagnostic yield for unselected chronic cough cases.
- Refractory chronic cough presents a diagnostic challenge, often requiring advanced investigations.
Purpose of the Study:
- To evaluate the diagnostic yield of FB for chronic cough in patients with nonlocalizing chest roentgenograms who failed other diagnostic efforts.
- To identify predictors of positive FB findings in this specific patient cohort.
Main Methods:
- A retrospective analysis of 25 patients undergoing FB for chronic cough over a four-year period.
- Inclusion criteria: nonlocalizing chest roentgenograms, refractory cough, and failure of empiric therapies.
- Analysis of diagnostic findings and patient demographics, including age, sex, and cough duration.
Main Results:
- FB yielded a diagnosis in 7 (28%) of 25 patients.
- Specific diagnoses included broncholithiasis, tracheobronchopathia osteochondroplastica, tuberculous bronchostenosis, laryngeal dyskinesia, and arytenoid polyp.
- Older age (>50 years) and female sex were independent predictors of positive findings (p=0.02).
- No tracheobronchial neoplasms were detected.
Conclusions:
- Fiberoptic bronchoscopy offers a respectable diagnostic yield for carefully selected patients with refractory chronic cough and nonlocalizing chest roentgenograms.
- The procedure is a reasonable diagnostic tool when other methods have failed, particularly in older female patients.